secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001683168-24-000865
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma repurchases and cancels warrants for ~21.6M shares for $3.14M total
--------------------------------------------------------------------------------

- Bought back May 2023 warrants for 11,904,762 shares from Armistice Capital for $2,361,596; warrants cancelled.
- Bought back April 2022 warrants for 9,725,690 shares from holders for $0.08 each ($778,055 total); cancelled.
- Armistice Capital waived variable-rate transaction prohibition under the May 2023 securities purchase agreement.
- Combined repurchase eliminates potential dilution from ~21.6M shares; cash outlay ~$3.14M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824000865/0001683168-24-000865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824000865/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-000865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer